Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant

被引:17
作者
Kumano, Osamu [1 ]
Moore, Gary W. [2 ]
机构
[1] Sysmex Corp, Prot Technol, Kobe, Hyogo, Japan
[2] Guys & St Thomas Hosp, Viapath Analyt, Dept Haemostasis & Thrombosis, London, England
关键词
activated partial thromboplastin time; antiphospholipid antibodies; antiphospholipid syndrome; diluted Russell's viper venom time; lupus anticoagulant; CLOTTING TIME; GUIDELINES; SENSITIVITY; REAGENTS; MANAGEMENT; DIAGNOSIS; UPDATE;
D O I
10.1002/rth2.12245
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Lupus anticoagulant (LA) is classified in the antibody family that is recognized in antiphospholipid syndrome. Mixing tests are recommended for LA detection, and either a mixing test-specific cutoff (MTC) or index of circulating anticoagulant (ICA) is used for the interpretation. Although we previously showed MTC had higher sensitivity for LA than ICA, there are few studies investigating specificity. Objectives To investigate specificity of multiple activated partial thromboplastin time (APTT) and diluted Russell's viper venom time (dRVVT) reagents for inhibitors using plasmas with non-LA causes of prolonged clotting times, interpreted with MTC and ICA. Methods Seventy-six factor-deficient samples (either artificially prepared, hereditary deficiency, or warfarin), and 12 inhibitors (either coagulation factor inhibitors, rivaroxaban, or apixaban) were used. Samples were tested with 4 APTTs, 1 dilute APTT (dAPTT), and 2 dRVVT reagents, and all elevated screen ratios were followed up with mixing tests. Frequencies of corrected and not-corrected results were calculated. Results The frequency of MTC and ICA corrected results, suggesting factor deficiency, were 5% to 43% and 79% to 100%, respectively, except for dAPTT, where MTC and ICA performed similarly. Frequencies of MTC and ICA not-corrected results, suggesting inhibition, were 29% to 100% and 25% to 67%, respectively. Conclusions The data indicate that MTC has a tendency to generate not-corrected mixing tests in factor-deficient, warfarin, and other inhibitor samples, while ICA exhibited higher specificity. When we perform the mixing test and interpret the data, it is important to understand the characteristics of the indexes for maximizing the diagnostic potential of mixing test.
引用
收藏
页码:695 / 703
页数:9
相关论文
共 30 条
  • [21] Frequent False-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin
    Martinuzzo, M. E.
    Barrera, L. H.
    D'Adamo, M. A.
    Otaso, J. C.
    Gimenez, M. I.
    Oyhamburu, J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 (02) : 144 - 150
  • [22] Pathogenesis of antiphospholipid syndrome: understanding the antibodies
    Meroni, Pier Luigi
    Borghi, M. Orietta
    Raschi, Elena
    Tedesco, Francesco
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (06) : 330 - 339
  • [23] International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    Miyakis, S
    Lockshin, MD
    Atsumi, T
    Branch, DW
    Brey, RL
    Cervera, R
    Derksen, RHWM
    De Groot, PG
    Koike, T
    Meroni, PL
    Reber, G
    Shoenfeld, Y
    Tincani, A
    Vlachoyiannopoulos, PG
    Krilis, SA
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) : 295 - 306
  • [24] Further evidence of false negative screening for lupus anticoagulants
    Moore, G. W.
    Henley, A.
    Greenwood, C. K.
    Rangarajan, S.
    [J]. THROMBOSIS RESEARCH, 2008, 121 (04) : 477 - 484
  • [25] The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied
    Moore, Gary W.
    Savidge, Geoffrey F.
    [J]. THROMBOSIS RESEARCH, 2006, 118 (04) : 523 - 528
  • [26] Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant
    Moore, Gary W.
    Culhane, Aidan P.
    Daw, Christopher R.
    Noronha, Charlotte P.
    Kumano, Osamu
    [J]. THROMBOSIS RESEARCH, 2016, 139 : 98 - 101
  • [27] Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants
    Moore, Gary W.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (02) : 163 - 171
  • [28] Acquired hemophilia: a case report and review of the literature
    Mulliez, S. M. N.
    Vantilborgh, A.
    Devreese, K. M. J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 (03) : 398 - 407
  • [29] Update of the guidelines for lupus anticoagulant detection
    Pengo, V.
    Tripodi, A.
    Reber, G.
    Rand, J. H.
    Ortel, T. L.
    Galli, M.
    de Groot, P. G.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (10) : 1737 - 1740
  • [30] Lupus-anticoagulant testing at NOAC trough levels
    Ratzinger, Franz
    Lang, Mona
    Belik, Sabine
    Jilma-Stohlawetz, Petra
    Schmetterer, Klaus G.
    Haslacher, Helmuth
    Perkmann, Thomas
    Quehenberger, Peter
    [J]. THROMBOSIS AND HAEMOSTASIS, 2016, 116 (02) : 235 - 240